Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Peregrine Pharmaceuticals Inc

+ Add to Watchlist

PPHM:US

1.3200 USD 0.0100 0.75%

As of 17:20:00 ET on 05/22/2015.

Snapshot for Peregrine Pharmaceuticals Inc (PPHM)

Open: 1.3300 Day's Range: 1.3100 - 1.3400 Volume: 1,126,481
Previous Close: 1.3300 52wk Range: 1.1900 - 2.0000 1-Yr Rtn: -23.70%

Stock Chart for PPHM

No chart data available.
  • PPHM:US 1.3200
  • 1D
  • 1M
  • 1Y
1.3300
Interactive PPHM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PPHM

Current P/E Ratio (ttm) -
Estimated P/E(04/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2900
Est. EPS (USD) (04/2015) -0.3000
Est. PEG Ratio -
Market Cap (M USD) 248.60
Shares Outstanding (M) 188.33
30 Day Average Volume 892,878
Price/Book (mrq) 7.9951
Price/Sale (ttm) 9.9013
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PPHM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PPHM

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the research, development and commercialization of novel therapeutics for cancer and a wide range of viral diseases.

Steven W KingPresident/CEOPaul J LytleChief Financial Officer
Mark R ZiebellVP/Secretary/General CounselShelley P M FusseyVP:Intellectual Property
More Company Profile & Key Executives for PPHM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil